Protect Pharmaceutical
(OTC) PRTT
Protect Pharmaceutical Financials at a Glance
Market Cap
$3.55M
Revenue (TTM)
$112.39M
Net Income (TTM)
$49.34M
EPS (TTM)
$0.86
P/E Ratio
0.07
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$0.06
Volume
10,000
Open
$0.05
Price
$0.06
Volume
10,000
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.06
52-Week Range
$0.02 - $1.69
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$0.06
Volume
10,000
Open
$0.05
Previous Close
$0.06
Daily Range
$0.05 - $0.06
52-Week Range
$0.02 - $1.69
PRTT News
PRTT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protect Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareCEO
Ozgur Ozcan
Website
www.protectpharma.comHeadquarters
Las Vegas, NV 89115, US
PRTT Financials
Key Financial Metrics (TTM)
Gross Margin
60%
Operating Margin
44%
Net Income Margin
44%
Return on Equity
15%
Return on Capital
14%
Return on Assets
12%
Earnings Yield
14.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.55M
Shares Outstanding
57.45M
Volume
10.00K
Short Interest
0.00%
Avg. Volume
13.25K
Financials (TTM)
Gross Profit
$72.56M
Operating Income
$57.64M
EBITDA
$57.64M
Operating Cash Flow
$12.71M
Capital Expenditure
$2.52M
Free Cash Flow
$10.19M
Cash & ST Invst.
$73.94M
Total Debt
$3.83M
Protect Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.34M
-42.1%
Gross Profit
$14.67M
-29.5%
Gross Margin
55.70%
N/A
Market Cap
$3.55M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$6.63M
-50.8%
EBITDA
$8.84M
-34.4%
Quarterly Fundamentals
Net Cash
$71.36M
+20.6%
Accounts Receivable
$60.64M
-12.7%
Inventory
$124.77M
+50.3%
Long Term Debt
$0.00
N/A
Short Term Debt
$4.41M
+14.1%
Return on Assets
11.66%
N/A
Return on Invested Capital
14.37%
N/A
Free Cash Flow
$4.57M
-276.9%
Operating Cash Flow
$2.10M
-181.3%